MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Magazine
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Navigation Corner
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • Keep in Touch!

When Cancer Moves Fast: Understanding Visceral Crisis and Urgent Oncologic Decisions

by MedOncMD on May 14, 2025

Disclaimer: The following stories and cases are generalized for educational purposes. All patient-identifying details have been significantly modified or omitted.

Over the past few months, I’ve encountered several powerful cases—both clinically and through consult work—that highlight an urgent and often misunderstood reality in oncology: impending visceral crisis.

Visceral crisis refers to a rapidly deteriorating state caused by cancer, often marked by near compromised organ function, bulky disease, or acute symptoms that require immediate intervention. These aren’t slow, watch-and-wait situations. These are moments when timing is everything, and the decisions made in a hospital room can mean the difference between recovery and decline.

Let me share some general experiences and insights:

Case Reflections:

  1. Bulky Lymphoma and the Window Missed
    A patient presented with bulky lymphadenopathy, bilateral DVTs, and was ultimately diagnosed with high grade lymphoma. There were complications from initial procedures, but the disease was chemosensitive. The inpatient team urged starting chemotherapy during hospitalization while the patient was stabilized. The patient hesitated, preferring to be discharged and return later as an outpatient. That moment—of indecision—became the decision. Weeks passed, performance status declined, appetite waned, and by the time outpatient treatment was considered, it was too late. This wasn’t about fault. It was about timing. About opportunity missed.
  2. Visceral Liver Involvement: A Delicate Tipping Point
    In another instance, a patient presented with newly diagnosed metastatic colorectal cancer—80-90% of the liver replaced by tumor. Liver function was borderline. One more step, one more cell, and fulminant liver failure loomed.  Once a patient goes into fuliminant liver failure then survival is days to weeks.  Best supportive care with hospice planning is typically the best course of action.  These are cases where chemotherapy isn’t just a plan—it’s a lifeline.  It’s a chance to reset the clock and bridge to continue therapy as an outpatient.  Therapy needs to begin urgently, sometimes inpatient or sometimes within days of initial consultation as an outpatient. The clock is ticking.
  3. Urgency with Potential: The Lazarus Response
    Certain cancers are uniquely chemosensitive—testicular cancer, lymphoma, small cell lung cancer, kaposi sarcoma, even melanoma with BRAF mutations. When treated quickly and appropriately, these patients can have a dramatic reversal of symptoms. Some walk out of the ICU after treatment begins. That kind of response—the Lazarus effect—requires swift, decisive action.

Key Considerations in Visceral Crisis:

  1. Time to Response Matters
    Liquid malignancies such myeloma, lymphoma, leukemia are well known to respond rapidly with therapy.  Some solid cancers as aforementioned can also respond in days to weeks. Regimens are chosen not just for efficacy but speed or response rate. Time to response is critical.
  2. Hospital-Based Therapy Is Sometimes Essential
    In select cancers, starting chemotherapy or radiation in the hospital can stabilize organ function and allow safe transition to outpatient care.
  3. Indecision Is a Decision
    Delaying therapy—whether from uncertainty, fear, or lack of understanding—can close a narrow window of opportunity.  
  4. Supportive Care as a Bridge
    Procedures like biliary drains, stents, feeding tubes, or bowel diversions can stabilize patients and buy time for outpatient therapy.
  5. New Paradigms in Care
    Drugs previously reserved for outpatient use—like BRAF-targeted therapy in melanoma—are now feasible inpatient due to improved access programs and institutional readiness.  
  6. Don’t Dismiss Inpatient Therapy
    Even in historically less-responsive cancers, newer treatments may change the game barring financial constraints/drug access issues. The decision depends on the patient’s status, tumor type, and access to resources.
  7. Heed Your Oncologist’s Urgency
    If a medical team recommends therapy during hospitalization, it’s not because they want to rush you—it’s because they see a narrow path that might still offer hope. A small window of opportunity to act decisively. 

Visceral crisis isn’t always obvious to the patient or family. Four to six weeks ago, everything may have felt fine. But cancer—when aggressive—can move fast. Recognizing that urgency, and acting on it, can mean everything.

As oncologists, we’re trained to recognize these tipping points. When we recommend inpatient therapy, it’s not from convenience—it’s from experience.

If you or a loved one finds themselves acutely ill due to cancer, remember: this isn’t just a hospital stay. It may be the moment where the path forward is decided.

Let’s act while we can. Let’s not miss the moment. Let’s change the outcome, together.


About the author

Dr. Sajeve Thomas is a distinguished medical professional and a compassionate guide in the field of oncology. With over a decade of dedicated experience as a board-certified medical oncologist/internal medicine specialist, Dr. Thomas has become a trusted expert in the treatment of melanoma, sarcoma, and gastrointestinal conditions. He brings a wealth of expertise to the complex and challenging world of oncology.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • When Cancer Moves Fast: Understanding Visceral Crisis and Urgent Oncologic Decisions
  • The Story Behind the Logo: Building the Bridge, Stone by Stone
  • Remembering Dr. Craig Kitchens: The Legacy of a Great Physician
  • Six Months Later: Rediscovering Balance Through Locum Life and New Ventures
  • When Delay Becomes Harm: A Clinician’s Reflection on Timely Cancer Care

Categories

  • Art of Oncology (79)
  • Current News (12)
  • Immunotherapy News (9)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Research Advances (108)
    • Clinical Trials (43)
    • Immunotherapy (29)
    • New Treatments and Therapies (42)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (114)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (13)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (2)
    • Lung Cancer (10)
    • Lymphoma (3)
    • Melanoma (28)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (4)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (7)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Magazine
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Navigation Corner
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • Keep in Touch!
© 2025 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Magazine
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Navigation Corner
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • Keep in Touch!